Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monica Javidnia
Observed name:
Javidnia, Monica
Institutions:
University of Rochester Medicine,
University of Rochester
Observed institutions:
United States Department of Health and Human Services,
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Georgetown University,
Georgetown University Medical Center,
University of Rochester Medicine,
University of Rochester
show all 7
ORCID:
0000-0002-3787-8672
Observed ORCID:
0000-0002-3787-8672
OpenAlex ID:
A5017221991
Klotho Regulates Retinal Pigment Epithelial Functions and Protects Against Oxidative Stress
2013
·
Maria Kokkinaki
, Mones Abu-Asab
, et al.
·
Journal of Neuroscience
·
78
PDF
A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
2018
·
Kalpana M. Merchant
, Jesse M. Cedarbaum
, et al.
·
Journal of Parkinson s Disease
·
63
PDF
Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease
2021
·
Charles S. Venuto
, Luoying Yang
, et al.
·
Annals of Clinical and Translational Neurology
·
53
PDF
Tau clearance improves astrocytic function and brain glutamate-glutamine cycle
2018
·
Michaeline L. Hebron
, Monica Javidnia
, et al.
·
Journal of the Neurological Sciences
·
51
Responses to 10 common criticisms of anti-racism action in STEMM
2021
·
Maya L. Gosztyla
, Lydia Kwong
, et al.
·
PLoS Computational Biology
·
34
PDF
Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy
2017
·
Monica Javidnia
, Michaeline L. Hebron
, et al.
·
Journal of Alzheimer s Disease
·
33
Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors
2015
·
John O. DiRaddo
, Eric J. Miller
, et al.
·
Molecular Pharmacology
·
22
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling
2021
·
Monica Javidnia
, Lakshmi Arbatti
, et al.
·
Journal of Parkinson s Disease
·
21
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation
2021
·
Malidi Ahamadi
, Nitin Mehrotra
, et al.
·
Clinical Pharmacology & Therapeutics
·
19
Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge
2023
·
Solveig K. Sieberts
, Henryk Borzymowski
, et al.
·
PLOS Digital Health
·
12
PDF
Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative Participants
2020
·
Monica Javidnia
, Ira Shoulson
, et al.
·
Journal of Parkinson s Disease
·
8
An update on clinical trials targeting human tauopathies
2017
·
CharbelE-H Moussa
, Monica Javidnia
, et al.
·
Clinical Trials in Degenerative Diseases
·
6
Addressing the need for standardization of symptomatic medication documentation in Parkinson's disease clinical research: A call to action
2025
·
Mikayla Spott
, Monica Javidnia
, et al.
·
Journal of Parkinson s Disease
·
4
Remote Regulatory Assessments of Bioavailability/Bioequivalence Study Conduct by the Office of Study Integrity and Surveillance
2024
·
Monica Javidnia
, Hasan A. Irier
, et al.
·
AAPS PharmSciTech
·
1
PDF
The Unmet Needs of People with Parkinson’s Disease and How They Relate to Current Late-Stage Clinical Trials
2022
·
Jasmine Moon
, Monica Javidnia
·
medRxiv
PDF
[p1–202]: Pazopanib Reduces Phosphorylated Tau Levels and Reverses Inflammation in Mice
2017
·
Monica Javidnia
, Michaeline Hebron
, et al.
·
Alzheimer s & Dementia
Pazopanib Reduces Tau Pathology and Restores Astrocytes in a Novel Mouse Model of Neurodegenerative Tauopathy
2017
·
Monica Javidnia
·
DigitalGeorgetown (Georgetown University Library)
P4‐035: Pazopanib is a Potential Therapeutic for Tauopathies
2016
·
Monica Javidnia
, Michaeline Hebron
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
19
Citation count:
405
H-index:
10
I10-index:
10
Year
Topic
Type